---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-156416"
form_type: "8-K"
ticker: "WW"
cik: "0000105319"
company_name: "WW INTERNATIONAL, INC."
filed_at: "2025-07-08T23:59:59+00:00"
generated_at: "2026-05-18T09:00:03.850264+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# WeightWatchers completes financial reorganization, relists on Nasdaq; appoints new CMO and board members

## Summary
- Completed financial reorganization with enhanced flexibility; relisted on Nasdaq under ticker WW on July 8, 2025.
- Appointed Dr. Kim Boyd as Chief Medical Officer; she previously led at One Medical, Calibrate, and Nurx.
- New board includes Mike Mason (former Eli Lilly president of Diabetes & Obesity), Fallon O’Connor-Brooks, and others.
- Will launch a perimenopause/menopause program later in 2025 combining medical, nutritional, and community support.
- Appointed Uta Knablein as Chief Product Officer; promoted Jacquie Cooke to CLO and Jon Volkmann to COO.

## SEC filing metadata
- accession: 0001193125-25-156416
- form_type: 8-K
- ticker: WW
- cik: 0000105319
- company_name: WW INTERNATIONAL, INC.
- filed_at: 2025-07-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/105319/000119312525156416/0001193125-25-156416-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/105319/000119312525156416/d83528d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-156416
- JSON: https://secwatch.observer/filing/0001193125-25-156416.json
- Plain text: https://secwatch.observer/filing/0001193125-25-156416.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.